Clinical reality
The most valuable healthcare AI does not start in a notebook. It starts in the reality of protocols, endpoints, site operations, and regulatory expectations.
Bridging clinical trials and artificial intelligence with the rigor that modern healthcare demands.
The most valuable healthcare AI does not start in a notebook. It starts in the reality of protocols, endpoints, site operations, and regulatory expectations.
Biostatistics and clinical strategy are not optional layers at the end of a project. They are the conditions that determine whether an innovation can be trusted, validated, and approved.
Clinical AI needs clinical trialists at the table from day one — not only to test the output, but to define what good evidence looks like.
There are people who speak fluently about biostatistics, trial design, and regulatory submissions — but have never written a line of Python. There are people who build sophisticated ML pipelines — but have never read a protocol or an FDA guidance document.
BioSpark sits at the intersection.
If you're a biotech, a pharma company, or a healthcare SME looking for someone who speaks biostatistics and regulatory submissions as fluently as Python, machine learning, and cloud infrastructure — let's talk.